References
- Firth BG, Yancy CW Jr. Survival in congestive heart failure: have we made a difference? Am J Med 1990: 88(1N): 3–8N
- Chakko S, de Marchena E, Kessler KM, et al. Ventricular arrhythmias in congestive heart failure. Clin Cardiol 1989: 12(9): 525–30
- Wilber DJ, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988: 318(1): 19–24
- Bigger JT Jr, Fleiss JL, Meiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984: 69(2): 250–8
- Chakko CS, Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985: 109(3 Pt 1): 497–504
- Hine LK, Laird NM, Hewitt P, et al. Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. JAMA 1989: 262(21): 3037–40
- The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989: 321(6): 406–12
- Wilber DJ, Olshansky B, Moran JF, et al. Electrophysiological testing and nonsustained ventricular tachycardia: use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990: 82(2): 350–8
- Gomes JA, Winters SL, Stewart D, et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 1987: 10(2): 349–57
- Graboys TB, Lown B, Podrid PJ, et al. Long- term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982: 50(3): 437–43
- Raskin JN, DiMarco JP, Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 1980: 303(11): 607–13
- A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982: 247(12): 1707–14
- Chadda K, Goldstein S, Byington R, et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986: 73(3): 503–10
- Waagstein F, Caidahl K, Wallentin I, et al. Long-term beta-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989: 80(3): 551–63
- Slater W, Lampert S, Podrid PJ, et al. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs. Am J Cardiol 1988: 61(4): 349–53
- Ravid S, Podrid PJ, Lampert S, et al. Congestive heart failure induced bv six of the newer antiarrhythmic drugs. J Am Coll Cardiol 1989: 14(5): 1326–30
- Woosley RL, Echt DS, Roden DM. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. Am J Cardiol 1986: 57(3): 25–33B
- Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988: 77(4): 721–30
- Wilson JR. Use of antiarrhythmic drugs in patients with heart failure: clinical efficacy, hemodynamic results, and relation to survival. Circulation 1987: 75(Suppl IV): IV64–70
- Podrid PJ, Schoeneberger A, Lown B. Congestive heart failure caused by oral disopyramide. N Engl J Med 1980: 302(11): 614–7
- Greene HL, Richardson DW, Hallstrom AP, et al. Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes: Cardiac Arrhythmia Pilot Study. Am J Cardiol 1989: 63(7): 393–8
- Selzer A, Wray HW. Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 1964: 30(Jul): 17–26
- Velebit V, Podrid P, Lown B, et al. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982: 65(5): 886–94
- Podrid PJ, Lampert S, Graboys TB, et al. Aggravation of arrhythmia by antiarrhythmic drugs: incidence and predictors. Am J Cardiol 1987: 59(11): 38–44E
- Rae AP, Kay HR, Horowitz LN, et al. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing. J Am Coll Cardiol 1988: 12(1): 131–9
- Bigger JT Jr, Sahar DI. Clinical types of proarrhythmic response to antiarrhythmic drugs. Am J Cardiol 1987: 59(11): 2–9E